Changing Lives Through Research
Please be reassured that the ICVI is continuing its vital work as much as it is able to at this difficult time.
Professor Dalgleish is currently working towards designing a trial for a vaccine for COVID-19. Details can be seen behind the paywall at https://www.telegraph.co.uk/news/2020/03/30/have-found-missing-ingredient-coronavirus-vaccine/ - if you would like further details on this please use the email address below to contact us.
Our researchers are working at our labs at St George’s University of London if their work is classed as trial related, or working from home if applicable.
Our clinical trials are continuing with current patients, although we are unable to accept new ones.
Our charity office is closed at the moment and we are working from home. For any urgent enquiries, including press enquiries please email [email protected] with details and a phone number and someone will respond to your email.
Founded in 2000, the Institute for Cancer Vaccines and Immunotherapy is a unique charity which exclusively funds research into cancer immunotherapy and vaccines.
Our Principal, Professor Angus Dalgleish, Professor of Oncology at St. George’s University of London, has been a pioneer in this type of research for many years. ICVI raises funds to support his research team. All research is directly informed by Professor Dalgleish’s patients. This unique dynamic enables the improvement of patients’ survival rates and their quality of life for a wide range of cancers. We believe this is the future of cancer research.Read More